Search Results - "Hara, Y"

Refine Results
  1. 1

    Presence and quantification of pathogenic Arcobacter and Campylobacter species in retail meats available in Japan by Ohnishi, T., Hara‐Kudo, Y.

    Published in Letters in applied microbiology (01-07-2021)
    “…We present estimations for the amounts of Arcobacter (A. butzleri, A. cryaerophilus and A. skirrowii) and Campylobacter (C. jejuni, C. coli and C. fetus)…”
    Get full text
    Journal Article
  2. 2

    Site occupancy, valence state, and spin state of Co ions in Co-doped In2O3 diluted magnetic semiconductor by Kumagai, H., Hara, Y., Sato, K.

    “…•Co2+ and Co3+ ions tend to occupy the 24d and 8b sites, respectively.•Co2+ ions are dominant at low-doping region (x≤0.044) and that Co3+ ions appear at…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Vaspin prevents methylglyoxal-induced apoptosis in human vascular endothelial cells by inhibiting reactive oxygen species generation by Phalitakul, S., Okada, M., Hara, Y., Yamawaki, H.

    Published in Acta Physiologica (01-11-2013)
    “…Aim Vaspin (visceral adipose tissue‐derived serine protease inhibitor) is a novel adipocytokine found in visceral white adipose tissues of obese type 2…”
    Get full text
    Journal Article
  5. 5

    Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors by Chaudhuri, Aadel A, Tang, Chad, Binkley, Michael S, Jin, Michelle, Wynne, Jacob F, von Eyben, Rie, Hara, Wendy Y, Trakul, Nicholas, Loo, Billy W, Diehn, Maximilian

    Published in Lung cancer (Amsterdam, Netherlands) (01-07-2015)
    “…Highlights • Study of central lung tumors treated with stereotactic ablative radiotherapy (SABR). • We define “ultra-central” to refer to tumors directly…”
    Get full text
    Journal Article
  6. 6

    Self-Walking Gel by Maeda, S., Hara, Y., Sakai, T., Yoshida, R., Hashimoto, S.

    Published in Advanced materials (Weinheim) (05-11-2007)
    “…You'll never walk alone? A gel actuator that can generate autonomous motility with a wormlike motion without external driving stimuli is produced. The…”
    Get full text
    Journal Article
  7. 7

    Engineering yeast with a light-driven proton pump system in the vacuolar membrane by Daicho, Kaoru M, Hirono-Hara, Yoko, Kikukawa, Hiroshi, Tamura, Kentaro, Hara, Kiyotaka Y

    Published in Microbial cell factories (03-01-2024)
    “…The supply of ATP is a limiting factor for cellular metabolism. Therefore, cell factories require a sufficient ATP supply to drive metabolism for efficient…”
    Get full text
    Journal Article
  8. 8

    Evolutionary approach for improved proton pumping activity of heterologous rhodopsin expressed in Escherichia coli by Otsuka, Kensuke, Seike, Taisuke, Toya, Yoshihiro, Ishii, Jun, Hirono-Hara, Yoko, Hara, Kiyotaka Y., Matsuda, Fumio

    Published in Journal of bioscience and bioengineering (01-12-2022)
    “…A light-driven ATP regeneration system using rhodopsin has been utilized as a method to improve the production of useful substances by microorganisms. To…”
    Get full text
    Journal Article
  9. 9

    A Method of Solubilizing and Concentrating Astaxanthin and Other Carotenoids by Hara, Kiyotaka Y, Yagi, Shuwa, Hirono-Hara, Yoko, Kikukawa, Hiroshi

    Published in Marine drugs (16-08-2021)
    “…The valuable marine carotenoid, astaxanthin, is used in supplements, medicines and cosmetics. In this study, crustacyanin, an astaxanthin-binding protein, was…”
    Get full text
    Journal Article
  10. 10

    Implementation of a triple Gaussian beam model with subdivision and redefinition against density heterogeneities in treatment planning for scanned carbon-ion radiotherapy by Inaniwa, T, Kanematsu, N, Hara, Y, Furukawa, T, Fukahori, M, Nakao, M, Shirai, T

    Published in Physics in medicine & biology (21-09-2014)
    “…Challenging issues in treatment planning for scanned carbon-ion (C-ion) therapy are (i) accurate calculation of dose distribution, including the contribution…”
    Get more information
    Journal Article
  11. 11

    Metabolome analysis of metabolic burden in Escherichia coli caused by overexpression of green fluorescent protein and delta-rhodopsin by Matsuyama, Chinatsu, Seike, Taisuke, Okahashi, Nobuyuki, Niide, Teppei, Hara, Kiyotaka Y., Hirono-Hara, Yoko, Ishii, Jun, Shimizu, Hiroshi, Toya, Yoshihiro, Matsuda, Fumio

    Published in Journal of bioscience and bioengineering (01-03-2024)
    “…Overexpression of proteins by introducing a DNA vector is among the most important tools for the metabolic engineering of microorganisms such as Escherichia…”
    Get full text
    Journal Article
  12. 12

    Nuclear-interaction correction of integrated depth dose in carbon-ion radiotherapy treatment planning by Inaniwa, T, Kanematsu, N, Hara, Y, Furukawa, T

    Published in Physics in medicine & biology (07-01-2015)
    “…In treatment planning of charged-particle therapy, tissue heterogeneity is conventionally modeled as water with various densities, i.e. stopping effective…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    5-Aminolevulinic acid fermentation using engineered Saccharomyces cerevisiae by Hara, Kiyotaka Y, Saito, Masaru, Kato, Hiroko, Morikawa, Kana, Kikukawa, Hiroshi, Nomura, Hironari, Fujimoto, Takanori, Hirono-Hara, Yoko, Watanabe, Shigeyuki, Kanamaru, Kengo, Kondo, Akihiko

    Published in Microbial cell factories (07-11-2019)
    “…5'-Aminolevulinic acid (ALA) is widely used in the pharmaceutical industry, healthcare, and food production, and is a substrate for the biosynthesis of heme,…”
    Get full text
    Journal Article
  16. 16

    Regression of venous thrombus after trans‐sphenoidal hypophysectomy for pituitary‐dependent hyperadrenocorticism in a dog by Tanaka, S., Suzuki, S., Teshima, T., Yamashita, R., Hamamoto, Y., Hara, Y.

    Published in Journal of small animal practice (01-02-2023)
    “…An 8.0‐kg 8‐year‐old male dachshund was presented for surgical treatment of suspected pituitary‐dependent hyperadrenocorticism with portal vein thrombosis…”
    Get full text
    Journal Article
  17. 17

    High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML by Jo, A, Mitani, S, Shiba, N, Hayashi, Y, Hara, Y, Takahashi, H, Tsukimoto, I, Tawa, A, Horibe, K, Tomizawa, D, Taga, T, Adachi, S, Yoshida, T, Ichikawa, H

    Published in Leukemia (01-05-2015)
    “…EVI1 and MEL1 are homolog genes whose transcriptional activations by chromosomal translocations are known in small subsets of leukemia. From gene expression…”
    Get full text
    Journal Article
  18. 18

    Development of astaxanthin production from citrus peel extract using Xanthophyllomyces dendrorhous by Hara, Kiyotaka Y., Kageyama, Yuya, Tanzawa, Nanami, Hirono-Hara, Yoko, Kikukawa, Hiroshi, Wakabayashi, Keiji

    “…Developing a use for the inedible parts of citrus, mainly peel, would have great environmental and economic benefits worldwide. Astaxanthin is a value-added…”
    Get full text
    Journal Article
  19. 19

    Nontrivial Berry's phase and exotic quantum phenomena in the vicinity of the quantum limit in the three-dimensional Dirac system Bi0.97Sb0.03 by Salawu, Y.A., Sasaki, M., Yang, M., Wang, J.F., Hara, Y., Ohnishi, A., Kim, Heon-Jung

    “…[Display omitted] •Quantum oscillations on the three-dimensional (3D) Dirac material Bi0.97Sb0.03 single crystals in pulsed magnetic fields up to 50 T with…”
    Get full text
    Journal Article
  20. 20

    Carotenoid Nostoxanthin Production by Sphingomonas sp. SG73 Isolated from Deep Sea Sediment by Kikukawa, Hiroshi, Okaya, Takuma, Maoka, Takashi, Miyazaki, Masayuki, Murofushi, Keita, Kato, Takanari, Hirono-Hara, Yoko, Katsumata, Masahiro, Miyahara, Shoichi, Hara, Kiyotaka Y.

    Published in Marine drugs (14-05-2021)
    “…Carotenoids are used commercially for dietary supplements, cosmetics, and pharmaceuticals because of their antioxidant activity. In this study, colored…”
    Get full text
    Journal Article